Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03038438 · ClinicalTrials.gov registry record · NA
ABRE Clinical Study of the Abre Venous Self-expanding Stent System
A NA study, sponsored by Medtronic Endovascular.
- Completed
- Registry status
- NA
- Development phase
- 260
- Enrollment target
NCT03038438 is a NA study that has completed, run by Medtronic Endovascular. The registered enrollment target is 260 participants.
The verdict
NCT03038438, a NA study, has completed, sponsored by Medtronic Endovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
Study Summary
Evaluate the safety and effectiveness of the Abre venous self-expanding stent system for treatment of symptomatic iliofemoral venous outflow obstruction in patients with venous occlusive disease.
Interventions
- DEVICE Abre venous self-expanding stent system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2017-12-13 |
| Est. Completion | 2022-01-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03038438
The ClinicalTrials.gov registry entry for NCT03038438 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Abre venous self-expanding stent system is the first listed.
NCT03038438 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03038438 about?
NCT03038438 is a clinical study titled "ABRE Clinical Study of the Abre Venous Self-expanding Stent System". Evaluate the safety and effectiveness of the Abre venous self-expanding stent system for treatment of symptomatic iliofemoral venous outflow obstruction in patients with venous occlusive disease.
What is the current status of trial NCT03038438?
This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2017-12-13. Estimated completion is 2022-01-28.
What interventions are being tested in trial NCT03038438?
The interventions under investigation include: Abre venous self-expanding stent system (DEVICE).
Who is sponsoring clinical trial NCT03038438?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.